Daegu, South Korea

Hye Kyung Ju

This inventor holds 1 USPTO granted patent. Top assignee: Ewha University-Industry Collaboration Foundation. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hye Kyung Ju. Retrieved from https://idiyas.com/inventor/hye-kyung-ju-eare6ap8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hye Kyung Ju: Innovator in 5-Lipoxygenase Inhibition

Introduction

Hye Kyung Ju is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of biochemistry, particularly in the area of enzyme inhibition. His work focuses on developing methods that can have a profound impact on health and medicine.

Latest Patents

Hye Kyung Ju holds a patent for a "Method for inhibiting 5-lipoxygenase using a benzoxazole derivative." This innovative approach utilizes a benzoxazole derivative to effectively inhibit the enzyme 5-lipoxygenase, which is crucial in various inflammatory processes. His patent is a testament to his dedication to advancing scientific knowledge and therapeutic options.

Career Highlights

Hye Kyung Ju is affiliated with the Ewha University-Industry Collaboration Foundation, where he engages in research and development activities. His role at this institution allows him to collaborate with other experts and contribute to groundbreaking research in his field.

Collaborations

He has worked alongside talented colleagues, including Hea Young Park Choo and Hyeun Wook Chang. Their collaborative efforts enhance the research environment and foster innovation in their projects.

Conclusion

Hye Kyung Ju's contributions to the field of biochemistry, particularly through his patent on 5-lipoxygenase inhibition, highlight his role as an influential inventor. His work not only advances scientific understanding but also opens new avenues for therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…